Nuveen California Select Tax-Free Income Portfolio

NYSE:NXC

13.09 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 0.9240.9241.560.9241.0760.910.770.8661.7850.8842.2550.8931.8290.9181.9730.9181.8870.9481.5270.9390.9210.9210.9710.9711.0041.0041.0171.0171.0621.0621.0861.0861.1031.1031.1241.1241.1141.1141.1431.1431.1511.1511.161.161.1841.184
Cost of Revenue 000.1300.1300.13800.15100.15200.15200.15600.14800.142000000000000000000000000000
Gross Profit 0.9240.9241.430.9240.9460.910.6330.8661.6340.8842.1030.8931.6770.9181.8170.9181.740.9481.3840.9390.9210.9210.9710.9711.0041.0041.0171.0171.0621.0621.0861.0861.1031.1031.1241.1241.1141.1141.1431.1431.1511.1511.161.161.1841.184
Gross Profit Ratio 110.91710.87910.82110.91510.93310.91710.92110.92210.907111111111111111111111111111
Reseach & Development Expenses 0000000000000000000000000000000000000000000000
General & Administrative Expenses 0.0780.0780.080.080.0780.0780.0830.0830.0890.0890.090.090.0870.0870.0930.0930.0850.0850.0860.0860.1730.1730.0880.0880.0920.0920.0880.0880.0910.0910.0880.0880.0880.0880.0880.0880.090.090.0870.0870.0870.0870.0850.0850.0890.089
Selling & Marketing Expenses 0000000000000000000000000000000000000000000000
SG&A 0.0780.0780.080.080.0780.0780.0830.0830.0890.0890.090.090.0870.0870.0930.0930.0850.0850.0860.0860.1730.1730.0880.0880.0920.0920.0880.0880.0910.0910.0880.0880.0880.0880.0880.0880.090.090.0870.0870.0870.0870.0850.0850.0890.089
Other Expenses 000000-00000000-00002.616000000000000000000000000000
Operating Expenses 1.1331.1330.4310.4310.7660.7664.0054.0050.2640.2640.0680.0681.0471.0470.9830.9831.471.47-2.6161.0610.7270.7270.8660.8660.9890.9892.52.50.5360.5361.2521.2520.8340.8340.6870.6871.7381.7381.3591.3593.5173.5170.3370.3371.4991.499
Operating Income 0.8460.8460.9870.8440.2870.831-6.2790.7831.2380.7951.9220.8043.9310.832-0.1310.8254.8350.86340.8540.7480.7480.8830.8830.9120.9120.9280.9280.9710.9710.9980.9981.0151.0151.0361.0361.0241.0241.0571.0571.0641.0641.0751.0751.0961.096
Operating Income Ratio 0.9160.9160.6320.9130.2670.914-8.1510.9040.6940.90.8520.92.1490.906-0.0660.8992.5620.912.620.9090.8120.8120.9090.9090.9090.9090.9130.9130.9140.9140.9190.9190.920.920.9220.9220.9190.9190.9240.9240.9240.9240.9260.9260.9250.925
Total Other Income Expenses Net 3.2651.2090.143-0.350-0.687-7.062-3.9220.443-0.17600.1573.0991.1340-0.893.9721.55501.146-0.554-0.554-0.778-0.7781.081.08-3.894-2.4112.2260.6273.6781.34-0.746-0.7460.7750.7751.8271.8271.4451.445-3.432-3.4320.420.421.5861.586
Income Before Tax 4.1112.05600.49300.144-0-3.1400.61900.96101.965-0-0.06502.417420.1930.1930.1050.1051.9921.992-1.483-1.4831.5981.5982.3382.3380.2690.2691.8121.8122.8522.8522.5012.501-2.369-2.3691.4941.4942.6812.681
Income Before Tax Ratio 4.452.22500.53400.158-0-3.62500.70101.07602.14-0-0.07102.5512.622.1290.210.210.1080.1081.9851.985-1.458-1.4581.5051.5052.1522.1520.2440.2441.6111.6112.562.562.1882.188-2.058-2.0581.2881.2882.2642.264
Income Tax Expense 01.2090-0.350-0.687-0-3.9230-0.17600.15701.134-0-0.8901.5550.8541.146-0.554-0.554-0.778-0.7781.081.08-2.411-2.4110.6270.6271.341.34-0.746-0.7460.7750.7751.8271.8271.4441.444-3.434-3.4340.4170.4171.5841.584
Net Income 2.0562.0566.3620.4936.3620.1446.361-3.146.3590.6196.3560.9616.3531.9656.352-0.0656.352.417420.1930.1930.1050.1051.9921.992-1.483-1.4831.5981.5982.3382.3380.2690.2691.8121.8122.8522.8522.5012.501-2.369-2.3691.4941.4942.6812.681
Net Income Ratio 2.2252.2254.0780.5345.9130.1588.257-3.6253.5620.7012.8191.0763.4742.143.22-0.0713.3642.5512.622.1290.210.210.1080.1081.9851.985-1.458-1.4581.5051.5052.1522.1520.2440.2441.6111.6112.562.562.1882.188-2.058-2.0581.2881.2882.2642.264
EPS 0.650.326,362,2760.0786,361,8080.0231-0.4910.09710.1510.311-0.0110.380.630.310.0310.0310.0170.0170.310.31-0.24-0.240.250.250.370.370.0430.0430.290.290.450.450.40.4-0.38-0.380.240.240.430.43
EPS Diluted 0.650.32-1180.07860.0231-0.4910.09710.1510.311-0.0110.380.630.310.0310.0310.0170.0170.310.31-0.24-0.240.250.250.370.370.0430.0430.290.290.450.450.40.4-0.38-0.380.240.240.430.43
EBITDA 4.1131.2090.987-0.350.287-0.687-3.922-3.9221.238-0.1761.9220.1573.9311.134-0.131-0.894.8351.55541.146-0.361-0.554-0.778-0.77801.08-2.411-2.4110.6270.6271.341.34-0.746-0.7460.7750.7751.8271.8271.4451.445-3.432-3.4320.420.421.5841.584
EBITDA Ratio 4.4521.309-0.225-0.379-0.639-0.756-5.092-4.529-0.098-0.1990.070.1760.621.235-0.451-0.970.8241.6412.621.22-0.602-0.602-0.801-0.8011.0761.076-2.371-2.3710.5910.5911.2341.234-0.677-0.6770.690.691.641.641.2641.264-2.983-2.9830.3620.3621.3371.337